Results 261 to 270 of about 2,734,758 (393)
Novel bile acid therapeutics for the treatment of chronic liver diseases
V. Hegade +3 more
semanticscholar +1 more source
Objective Body mass index (BMI), glomerular filtration rate (GFR), and pretreatment urate levels have been reported to influence the urate‐lowering response to allopurinol. We investigated whether the fractional excretion of uric acid (FEUA) also modulates this response and relates to oxypurinol concentrations.
Pascal Richette +13 more
wiley +1 more source
Modulating the microbiome in chronic liver diseases - current evidence on the role of fecal microbiota transplantation. [PDF]
Saha S, Schnabl B.
europepmc +1 more source
Accelerated aging, genetic factors and risk of chronic liver diseases and mortality: findings from a prospective study [PDF]
Yu Jia, Xiaoyang Liao
openalex +1 more source
Objectives Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies. To help patients and providers in the decision‐making process, we developed
Anahita Deboo +19 more
wiley +1 more source
Noninvasive prediction of clinically significant portal hypertension in metabolic dysfunction-associated steatotic liver disease compared to other chronic liver diseases. [PDF]
Masood M, Thandassery RB.
europepmc +1 more source
Cognitive Behavioral Therapy for Youth with Childhood‐Onset Lupus: A Randomized Clinical Trial
Objective Our objective was to determine the feasibility and acceptability of the Treatment and Education Approach for Childhood‐onset Lupus (TEACH), a six‐session cognitive behavioral intervention addressing depressive, fatigue, and pain symptoms, delivered remotely to individual youth with lupus by a trained interventionist.
Natoshia R. Cunningham +29 more
wiley +1 more source
Adding salt to foods and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases. [PDF]
Zhang S +4 more
europepmc +1 more source

